Human Papillomavirus Market Increasing Prevalence of Cervical Cancer

According to Precision Business Insights (PBI), the latest report, the human papillomavirus market is expected to be valued at USD 4,376.3 million in 2022 and is poised to grow at a significant CAGR of 12.7% over 2022-2028. The primary drivers of the expansion of the global human papillomavirus market include the increasing vaccine supply, increasing prevalence of various types of cancers, and government and notable organizations initiatives and support.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/human-papillomavirus-market/

Cervical Cancer Segment to Dominate the Human Papillomavirus Market:
Based on disease indication, the human papillomavirus market is segmented into cervical cancer, anal cancer, vulvar & vaginal cancer, cancer, oropharyngeal cancer, and others. The cervical cancer is holding the highest market revenue share in 2021 during the forecast period. The increasing prevalence of cervical cancer is boosting the global human papillomavirus market growth at a significant rate. According to the World Health organization, cervical cancer is the fourth most common cancer in women. In 2018, an estimated 570 000 women were diagnosed with cervical cancer worldwide and about 311 000 women died from the disease. Hence, this segment will drive the global market growth further in the forecasted years.

Asia Pacific Human Papillomavirus Market
The Asia Pacific market is expected to increase in the global human papillomavirus market over the forecast period. The Asia Pacific market is expanding due to increasing cases of cancer diseases and increasing investment in healthcare sector. North America held considerable market share during the estimated period owing to the global market players in this region.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players.
The global human papillomavirus market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region.

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=62156

The human papillomavirus market is segmented based on type, disease indication, end-user, and geography.

Based on the type, the market is segmented into the following:
• Tetravalent
• Bivalent
• Polyvalent
• Others

Based on the disease indication, the market is segmented into the following:
• Cervical Cancer
• Anal Cancer
• Vulvar & Vaginal Cancer
• Cancer
• Oropharyngeal Cancer
• Others

Based on the end user, the market is segmented into the following:
• Hospitals & Retail Pharmacies
• Government Suppliers
• Others

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Request Methodology: https://precisionbusinessinsights.com/request-methodology/?product_id=62156

Key players' profiles in the human papillomavirus market report are Merck & Co, GlaxoSmithKline plc, Sanofi, Johnson & Johnson, AstraZeneca, Serum Institute, Bharat Biotech, Xenetic Biosciences, Inovio Pharmaceuticals, Novartis AG, and Roche.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.